Archon Biosciences
Healthcare & Life Sciences
Recent Finacing
Seed
Recent Raise
$20M
Archon Biosciences develops AI-driven Antibody Cages to enhance antibody treatments by improving target engagement and biodistribution.
Focus Areas
AI-driven
computational protein design
antibody treatments
novel protein structures
drug development
biologics manufacturing.
Investors
